Cross-sectional study examines psychological symptoms after anaphylaxis, highlighting the need for follow-up care.
Background: Anaphylaxis is an acute, potentially life-threatening systemic hypersensitivity reaction. Psychological symptoms, including anxiety, depressive symptoms, and post-traumatic stress symptoms (PTSS), may persist after the acute episode; however, adult data remain limited. Objective: To describe the prevalence and co-occurrence of psychological symptoms after anaphylaxis in adults and to examine their associations with clinical characteristics, acute severity indicators, and epinephrine/adrenaline auto-injector-related behaviors Methods: This single-center cross-sectional study included adults with medically confirmed anaphylaxis within the previous 6 months and at least 1 month beyond the index event. Anxiety and depressive symptoms were screened using the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A) and the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), respectively. Post-traumatic stress symptoms were assessed using the Post-traumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Short Form (PCL-5-S). Thresholds were HADS-A ≥10, HADS-D ≥7, and PCL-5-S ≥6. Positivity on at least one threshold was defined as combined psychological risk. Results: Seventy-five adults were included; the median age was 39 years, and 53.3% were female. The most common triggers were bee venom (38.7%) and drugs (29.3%). According to the World Allergy Organization severity grading system(WAO), 57.3% of reactions were classified as Grade 4–5. Above-threshold symptoms were observed in 14.7% for anxiety, 25.3% for depression, and 37.3% for PTSS; overall, 50.7% met at least one threshold. Psychometric scores were not significantly associated with reaction severity group, intensive care unit admission, or epinephrine/adrenaline administration. Depression scores differed by trigger type, with higher scores in idiopathic and drug-triggered cases. Conclusion: Psychological symptom burden was common in the early post-anaphylaxis period among adults and did not appear to parallel acute clinical severity. Brief multidomain psychological screening may support more comprehensive post-anaphylaxis follow-up and help identify patients who may benefit from further assessment or referral.
No takes yet. Share an insight, caveat, or question.
Savaş et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: